← Back to Search

Trauma-Informed Toolkit for HIV Prevention in African American Women

N/A
Waitlist Available
Led By Tiara C. Willie, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Non-English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 8-months after toolkit implementation in each clinic
Awards & highlights

Summary

This trial seeks to develop a toolkit to increase pre-exposure prophylaxis uptake among African American women in the south who experience high rates of intimate partner violence.

Who is the study for?
This trial is for African American women receiving care at community healthcare clinics in Mississippi, who are at risk for HIV infection and may also be dealing with intimate partner violence. Participants must speak and understand English.
What is being tested?
The study is testing a Trauma-Informed Toolkit designed to increase the use of Pre-Exposure Prophylaxis (PrEP) among African American women. It aims to address both HIV prevention and intimate partner violence within two clinics in Jackson, Mississippi.
What are the potential side effects?
Since this trial involves the implementation of an educational toolkit rather than a medical intervention, there are no direct side effects from medications or treatments being studied.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 8-months after toolkit implementation in each clinic
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 8-months after toolkit implementation in each clinic for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pre-Exposure Prophylaxis
Secondary study objectives
Clinic's %Pre-Exposure Prophylaxis Uptake
Clinic's Pre-Exposure Prophylaxis Coverage
Clinic's proportion of women with Pre-Exposure Prophylaxis retention

Trial Design

1Treatment groups
Experimental Treatment
Group I: Trauma-Informed Pre-Exposure Prophylaxis Implementation ToolkitExperimental Treatment1 Intervention
The Toolkit to be developed in the proposed study includes components from the women-specific Pre-Exposure Prophylaxis care continuum theoretical model and implementation challenges, and is adapted to identify and provide care to women experiencing intimate partner violence. Overall, the Toolkit is designed to create culturally-congruent, intimate partner violence-informed clinical settings; and equip clinical staff with the knowledge and skills they need to address HIV prevention for African American women; and integrate intimate partner violence into Pre-Exposure Prophylaxis care services.

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
418 Previous Clinical Trials
2,116,757 Total Patients Enrolled
Tiara C. Willie, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health

Media Library

Trauma-Informed Toolkit Clinical Trial Eligibility Overview. Trial Name: NCT05139069 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Trauma-Informed Pre-Exposure Prophylaxis Implementation Toolkit
Human Immunodeficiency Virus Infection Clinical Trial 2023: Trauma-Informed Toolkit Highlights & Side Effects. Trial Name: NCT05139069 — N/A
Trauma-Informed Toolkit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05139069 — N/A
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top